Historical data suggest that major IPOs don't usually flag a bull market peak in the year that follows. SpaceX is poised to launch the biggest IPO ever when it begins trading this Friday. But a recent analysis from Canaccord Genuity shows that broad stock market averages typically tend to outperform big IPOs after a year. "Recent history suggests large IPOs are not a headwind for index performance...
Historical data suggest that major IPOs don't usually flag a bull market peak in the year that follows. SpaceX is poised to launch the biggest IPO ever when it begins trading this Friday. But a recent analysis from Canaccord Genuity shows that broad stock market averages typically tend to outperform big IPOs after a year. "Recent history suggests large IPOs are not a headwind for index performance," the Canaccord analysts wrote. The investment bank reviewed the historical impact of the largest global listings since 2008, including seven IPOs that raised the largest dollar amounts of capital globally: Visa , Facebook , Alibaba , Aramco, Rivian , LG Energy Solution and ARM Holdings . Historical impact Historical data analyzed by Canaccord Genuity showed that, on average, the Nasdaq Composite gained 10.9% one year after the mega-sized IPOs, while S & P 500 rose a more modest 1.1%. Notably, index returns outpaced the IPOs themselves, which were down 4.2% on average over the same period. Most of the seven IPOs declined in their first year of trading, for example. Facebook, Alibaba, Aramco and Rivian also suffered sharp losses. Arm was the major exception, more than doubling, with a 132% gain. The Nasdaq rose over the following year after five of the seven jumbo IPOs, including gains of 42.2% after Facebook's 2012 IPO; 41.8% after ARM Holdings went public in 2023; and 20.3% one after Saudi Aramco's 2019 debut. The biggest one-year decline came after Visa's IPO in March 2008, which preceded the Global Financial Crisis. Over the next year, the Nasdaq collapsed 44.3% and the S & P 500 by 39.6%. Largest IPO ever SpaceX, led by CEO Elon Musk, plans to debut on Nasdaq on Friday. The expectation is the rocket company will raise $75 billion by selling 555.6 million shares at a price of $135 per share, the largest IPO ever on Nasdaq. The Nasdaq market recently made some changes this year , which could make it easier for IPOs such as SpaceX to enter the benchmark Nasdaq-100 index. ...
Pharmaceutical companies can offer investors huge returns if treatments under development become blockbuster drugs. Choosing between a speculative clinical-stage play and a dominant cash-flow engine requires careful thought, however. Deciding between Kyverna Therapeutics (NASDAQ:KYTX) and Vertex Pharmaceuticals (NASDAQ:VRTX) hinges on your risk tolerance and growth goals. Kyverna Therapeutics focu...
Pharmaceutical companies can offer investors huge returns if treatments under development become blockbuster drugs. Choosing between a speculative clinical-stage play and a dominant cash-flow engine requires careful thought, however. Deciding between Kyverna Therapeutics (NASDAQ:KYTX) and Vertex Pharmaceuticals (NASDAQ:VRTX) hinges on your risk tolerance and growth goals. Kyverna Therapeutics focuses on the frontier of cell therapy, specifically targeting autoimmune diseases with novel treatments. Vertex Pharmaceuticals, meanwhile, holds a near-monopoly in the cystic fibrosis market while expanding into new therapeutic areas. Both companies represent different ends of the biotech spectrum, making them a fascinating pair for investors seeking exposure to medical innovation. Kyverna Therapeutics operates as a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases. Its lead product candidate, KYV-101, is a CAR T-cell therapy designed to target and deplete B cells that cause various illnesses. The company is currently advancing clinical programs across rheumatology and neurology indications with active trials in both the United States and Germany. Continue reading
Dozens of cryptographically verified open source packages from Microsoft were compromised late last week to add advanced credential-stealing code that was triggered when developers opened them in AI coding agents. In all, multiple researchers said , 73 packages were flagged as malicious when automated systems on GitHub blocked them on the platform. Rather than noting they are malicious—and that de...
Dozens of cryptographically verified open source packages from Microsoft were compromised late last week to add advanced credential-stealing code that was triggered when developers opened them in AI coding agents. In all, multiple researchers said , 73 packages were flagged as malicious when automated systems on GitHub blocked them on the platform. Rather than noting they are malicious—and that developers who used AI agents to work with them should assume their systems are compromised—the Microsoft-owned GitHub said it disabled the packages “due to a violation of GitHub's terms of service.” The text went on to encourage the package owner to contact GitHub. Devs: Assume compromise and proceed accordingly It wasn’t until Monday that Microsoft even raised the possibility the packages were infected. In an email, the company stated: “We have temporarily removed some repositories as we investigate potential malicious content.” Read full article Comments
Justin Sullivan/Getty Images News Apple ( AAPL ) presented a range of AI-focused updates across its operating systems, including for macOS, iPadOS and watchOS, during its Worldwide Developers Conference on Monday, which was CEO Tim Cook's last time to lead the event before he steps down in September. Shares dipped less than 1% following the announcements. The new operating systems are called macOS...
Justin Sullivan/Getty Images News Apple ( AAPL ) presented a range of AI-focused updates across its operating systems, including for macOS, iPadOS and watchOS, during its Worldwide Developers Conference on Monday, which was CEO Tim Cook's last time to lead the event before he steps down in September. Shares dipped less than 1% following the announcements. The new operating systems are called macOS 27, iPadOS 27 and watchOS 27. New system architecture has made it easier for developers to integrate AI into their apps across all Apple devices. The updated version of Siri also plays a heavy role, as it has been transformed from a voice-controlled assistant to a much more capable AI companion that can help users manage and tackle tasks across all Apple devices. Apple utilized Google's ( GOOG )( GOOGL ) Gemini model to improve Siri. Apple's new Siri app can run on macOS, iPadOS, and iOS. There is even a new Siri tailored for watchOS, which also features a new, dynamic grid layout. However, watchOS 27 drops support for second-generation Apple Watch SE, the first-generation Apple Watch Ultra, and the Apple Watch Series 6, 7, 8 and 9. "Today we are taking the next big step forward in Apple Intelligence … this involves our new architecture, which is centered around you," said Craig Federighi, senior vice president of software engineering at Apple. "We embarked on a deep collaboration with Google to develop AI that can run on-device or in a private cloud." Apple Intelligence can also draw on the app ecosystem to find the most appropriate app for a task at hand. Data is only used for a user's request and is not shared. Apple said this is verified by a private, third-party overseer. iPhone and iPad apps now launch 30% faster for in-house and third-party apps. Photos appear up to 70% faster. AirDrop now occurs up to 80% quicker, the company said. Apple rebuilt the Search function across its iOS offerings to improve its ability to find items and emails. The new macOS is called Gol...
Along with new software for Macs and iPhones, Apple announced visionOS 27 during its keynote presentation at WWDC on Monday. Like its other platforms, visionOS 27 will feature Apple's updated Siri AI assistant and the new dedicated Siri app. You can use visual intelligence to ask Siri about content on visionOS's floating displays, or ask Siri about objects in the real world by looking at them. It ...
Along with new software for Macs and iPhones, Apple announced visionOS 27 during its keynote presentation at WWDC on Monday. Like its other platforms, visionOS 27 will feature Apple's updated Siri AI assistant and the new dedicated Siri app. You can use visual intelligence to ask Siri about content on visionOS's floating displays, or ask Siri about objects in the real world by looking at them. It will also support using the panoramas you've photographed as immersive scenes and environments in visionOS. Apple said the Vision Pro will be able to connect to Wi-Fi "up to 3x faster," and a new "extra-small" widget size will allow more customiza … Read the full story at The Verge.
Millennium Management portfolio manager Adam Grunfeld asked a New York judge to throw out a suit filed against him by Schonfeld Strategic Advisors , saying the rival hedge fund group was essentially trying to pressure him to join. Schonfeld sued Grunfeld in April for allegedly reneging on a March deal to move from Millennium, claiming he agreed to pay $11 million if he backed out. But in a Friday ...
Millennium Management portfolio manager Adam Grunfeld asked a New York judge to throw out a suit filed against him by Schonfeld Strategic Advisors , saying the rival hedge fund group was essentially trying to pressure him to join. Schonfeld sued Grunfeld in April for allegedly reneging on a March deal to move from Millennium, claiming he agreed to pay $11 million if he backed out. But in a Friday court filing, Grunfeld said that figure was a signing bonus he never received and Schonfeld was misusing a clawback provision in a “transparent and illegal attempt to coerce” him to move. Under Schonfeld’s theory, “Grunfeld would be penalized for the exact same amount if he started working at Schonfeld, received $11 million and then left, as if he decided not to join Schonfeld 15 days after signing the agreement, 15 months before his start date, and before receiving any compensation,” the portfolio manager’s lawyer wrote in the motion to dismiss the case. Read More: Schonfeld Sues Millennium’s Grunfeld Over Alleged ‘Gazumping’ A spokesperson for Schonfeld didn’t immediately respond to a request for comment. The court battle is one of the latest to erupt over an alleged “gazumping” — a term gaining currency amid the hedge fund talent wars for when a sought-after recruit is intercepted with a better offer, sometimes by their current employer, before starting at a new firm. In its suit, Schonfeld said the $11 million figure reflected front-loaded costs associated with its attempt to recruit Grunfeld as well as the “opportunity costs associated with forgoing recruiting and hiring other qualified portfolio managers pursuing similar strategies.” But Grunfeld said there was no reasonable tie between those costs and the “grossly disproportionate” damages Schonfeld is seeking. He said that such costs were not specifically addressed in the clawback provision “because Schonfeld valued them for what they actually are: zero dollars.” Schonfeld is also seeking unspecified damages for Gru...
The headline number is true and a little stale. The ALPS Clean Energy ETF (NYSEARCA:ACES) hit a 52-week high in late May and was tracking roughly a 32% gain on the year at that peak, with one outlet pegging the fund at a 19.4% gain in May alone. Then came last week. ACES closed Friday ... Clean Energy Is the S&P 500’s New Boss: ACES Up 29% YTD
The headline number is true and a little stale. The ALPS Clean Energy ETF (NYSEARCA:ACES) hit a 52-week high in late May and was tracking roughly a 32% gain on the year at that peak, with one outlet pegging the fund at a 19.4% gain in May alone. Then came last week. ACES closed Friday ... Clean Energy Is the S&P 500’s New Boss: ACES Up 29% YTD
Tempus AI (NASDAQ: TEM) is trying to build more than a diagnostics business. Its growing healthcare data platform, artificial intelligence tools, FDA progress, and pharma partnerships could create meaningful upside if the company can scale profitably. But the stock already reflects high expectations, making execution the key issue for investors. *Stock prices used were the market prices of June 1,...
Tempus AI (NASDAQ: TEM) is trying to build more than a diagnostics business. Its growing healthcare data platform, artificial intelligence tools, FDA progress, and pharma partnerships could create meaningful upside if the company can scale profitably. But the stock already reflects high expectations, making execution the key issue for investors. *Stock prices used were the market prices of June 1, 2026. The video was published on June 7, 2026. Continue reading